| scholarly article | Q13442814 |
| P2093 | author name string | A. Dueñas-González | |
| D. Arias | |||
| M. Candelaria | |||
| L. Cetina | |||
| E. de la Cruz-Hernández | |||
| E. Pérez-Cárdenas | |||
| A. González-Fierro | |||
| C. Trejo-Becerril | |||
| J. Chanona | |||
| L. Taja-Chayeb | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic epigenesis | Q64443099 |
| cervix uterine cancer | Q160105 | ||
| cisplatin | Q412415 | ||
| chemoradiotherapy | Q5090613 | ||
| P304 | page(s) | 386-391 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | European Journal of Gynaecological Oncology | Q27710826 |
| P1476 | title | Epigenetic therapy and cisplatin chemoradiation in FIGO stage IIIB cervical cancer | |
| P478 | volume | 31 |
| Q60305702 | Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells |
| Q33917356 | Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer |
| Q49404179 | Combined treatment with D-allose, docetaxel and radiation inhibits the tumor growth in an in vivo model of head and neck cancer |
| Q92702483 | Epigenetic Dysregulation at the Crossroad of Women's Cancer |
| Q26863429 | Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair |
| Q34700859 | New molecular targets against cervical cancer |
| Q26767185 | Novel agents and treatment techniques to enhance radiotherapeutic outcomes in carcinoma of the uterine cervix |
| Q38879058 | The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX. |
| Q27000542 | Trials with 'epigenetic' drugs: an update |
| Q36246366 | Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy |
Search more.